To understand if the loss of KLRB1, FANCA, and MAPK3 genes were relevant for NB progression, we analyzed in silico their expression and outcome in 786 NB patients, using the dataset summarized by Cangelosi et al. [37]. The gene discussed is KLRB1; the disease is neuroblastoma.